Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties

Z. Drahota, E. Palenickova, R. Endlicher, M. Milerova, J. Brejchova, M. Vosahlikova, P. Svoboda, L. Kazdova, M. Kalous, Z. Cervinkova, M. Cahova

. 2014 ; 63 (1) : 1-11.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14083255

In this study, we focused on an analysis of biguanides effects on mitochondrial enzyme activities, mitochondrial membrane potential and membrane permeability transition pore function. We used phenformin, which is more efficient than metformin, and evaluated its effect on rat liver mitochondria and isolated hepatocytes. In contrast to previously published data, we found that phenformin, after a 5 min pre-incubation, dose-dependently inhibits not only mitochondrial complex I but also complex II and IV activity in isolated mitochondria. The enzymes complexes inhibition is paralleled by the decreased respiratory control index and mitochondrial membrane potential. Direct measurements of mitochondrial swelling revealed that phenformin increases the resistance of the permeability transition pore to Ca(2+) ions. Our data might be in agreement with the hypothesis of Schäfer (1976) that binding of biguanides to membrane phospholipids alters membrane properties in a non-specific manner and, subsequently, different enzyme activities are modified via lipid phase. However, our measurements of anisotropy of fluorescence of hydrophobic membrane probe diphenylhexatriene have not shown a measurable effect of membrane fluidity with the 1 mM concentration of phenformin that strongly inhibited complex I activity. Our data therefore suggest that biguanides could be considered as agents with high efficacy but low specifity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14083255
003      
CZ-PrNML
005      
20150113080835.0
007      
ta
008      
150102s2014 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.932600 $2 doi
035    __
$a (PubMed)24182344
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Drahota, Zdeněk, $d 1932- $7 jn20000400531 $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic; Department of Physiology, Medical Faculty, Charles University, Hradec Kralove, Czech Republic
245    10
$a Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties / $c Z. Drahota, E. Palenickova, R. Endlicher, M. Milerova, J. Brejchova, M. Vosahlikova, P. Svoboda, L. Kazdova, M. Kalous, Z. Cervinkova, M. Cahova
520    9_
$a In this study, we focused on an analysis of biguanides effects on mitochondrial enzyme activities, mitochondrial membrane potential and membrane permeability transition pore function. We used phenformin, which is more efficient than metformin, and evaluated its effect on rat liver mitochondria and isolated hepatocytes. In contrast to previously published data, we found that phenformin, after a 5 min pre-incubation, dose-dependently inhibits not only mitochondrial complex I but also complex II and IV activity in isolated mitochondria. The enzymes complexes inhibition is paralleled by the decreased respiratory control index and mitochondrial membrane potential. Direct measurements of mitochondrial swelling revealed that phenformin increases the resistance of the permeability transition pore to Ca(2+) ions. Our data might be in agreement with the hypothesis of Schäfer (1976) that binding of biguanides to membrane phospholipids alters membrane properties in a non-specific manner and, subsequently, different enzyme activities are modified via lipid phase. However, our measurements of anisotropy of fluorescence of hydrophobic membrane probe diphenylhexatriene have not shown a measurable effect of membrane fluidity with the 1 mM concentration of phenformin that strongly inhibited complex I activity. Our data therefore suggest that biguanides could be considered as agents with high efficacy but low specifity.
650    _2
$a zvířata $7 D000818
650    _2
$a biguanidy $x farmakologie $7 D001645
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a respirační komplex I $x antagonisté a inhibitory $x fyziologie $7 D042967
650    _2
$a respirační komplex II $x antagonisté a inhibitory $x fyziologie $7 D042963
650    _2
$a respirační komplex IV $x antagonisté a inhibitory $x fyziologie $7 D003576
650    _2
$a inhibitory enzymů $x farmakologie $7 D004791
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metformin $x farmakologie $7 D008687
650    _2
$a jaterní mitochondrie $x účinky léků $x enzymologie $7 D008930
650    _2
$a fenformin $x farmakologie $7 D010629
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Páleníčková, Eliška. $7 xx0239890 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Endlicher, René $7 xx0228158 $u Department of Physiology, Medical Faculty, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Milerová, Marie, $d 1951- $7 xx0074144 $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Brejchová, J. $7 _AN081023 $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Vošahlíková, Miroslava $7 _AN062885 $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Svoboda, Petr $7 xx0140547 $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Kazdová, Ludmila, $d 1938- $7 xx0053119 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kalous, Martin, $d 1957- $7 mzk2004258360 $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Červinková, Zuzana, $d 1951- $7 nlk20020106444 $u Department of Physiology, Medical Faculty, Charles University, Hradec Kralove, Czech Republic
700    1_
$a Cahová, Monika $7 xx0070633 $u Center for Experimental Medicine, Institute for Clinical and Experimental medicine, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 63, č. 1 (2014), s. 1-11
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20150102 $b ABA008
991    __
$a 20150109131341 $b ABA008
999    __
$a ok $b bmc $g 1057927 $s 882363
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 63 $c 1 $d 1-11 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20150102

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace